Drive Change – Video from ACannabis 2023 presented by:
Adjunct Professor David Heilpern LLB LLM
Campaign Lead
Bee Mohamed
Campaign Coordinator
Drive Change – Video from ACannabis 2023 presented by:
Adjunct Professor David Heilpern LLB LLM
Campaign Lead
Bee Mohamed
Campaign Coordinator
“The Medicinal Cannabis Industry Australia is pleased and excited to launch the Olivia Newton-John Service to Industry award”, said Mr Peter Crock, MCIA Chair, “and we are particularly honoured to have Olivia’s husband Mr John Easterling with us at ACannabis to formerly open the call for nominations for the inaugural 2023 Service to Industry Award”.
Continue reading “MCIA launches Olivia Newton-John Service to Industry Award to recognise excellence in the medicinal cannabis industry”Medicinal Cannabis Industry Australia (MCIA) is the voice for Australia’s medicinal cannabis industry and is focused on representing the mutual interests of members to build a sustainable and responsible industry that is trusted, valued, puts patients first and recognised for its quality and innovation.
Epilepsy Action Australia (EAA) as the leading and oldest provider of epilepsy services nationwide, focuses on improving self-management skills, increasing wider public understanding of this devastating condition, and are at the forefront of partnering and funding research into interventions and treatments. EAA also operate CanGuide, an independent and impartial service providing information on cannabis-based medicine.
Continue reading “MCIA and Epilepsy Action Australia partner to deliver independent information for the medicinal cannabis industry”Growing The Industry Through Research, Collaboration and Innovation: Register now for ACannabis 2023
Continue reading “Don’t miss ACannabis 2023: Register Now”In October MCIA released data obtained from the Office of Drug Control that revealed the volume of medicinal cannabis produced by Australian cultivators, along with volumes of imports and exports. MCIA has now obtained data from TGA that sheds light on the nature of products sold in Australia.
Continue reading “MCIA investigations shine further light on Australia’s medicinal cannabis industry”On Thursday 27 October 2022 MCIA hosted a fireside chat and networking function. The focus of the event was on tips and tricks for the OTC market, product registration and advertising environment for S3 CBD.
Continue reading “MCIA Event: Tips and Tricks for the OTC Market”On 28 October 2022 held a workshop on “Tips for successfully engaging with Human Research Ethics Committee”. This workshop was designed to provide a forum for participants from across the medicinal cannabis industry, and particularly medicinal cannabis companies and research organisations, to discuss approaches to successfully engaging with HREC in the area of clinical trials involving unregistered medicinal cannabis therapeutic goods.
Continue reading “MCIA Workshop: Tips for successfully engaging with Human Research Ethics Committee”Please join MCIA and industry colleagues for a fireside chat and networking function. The focus will be on tips and tricks for the OTC market, product registration and advertising environment for S3 CBD.
Continue reading “MCIA Networking Event: Tips and Tricks for the OTC Market”Take advantage of our Early Bird pricing and secure your ticket today. Prices inc GST
Continue reading “ACannabis 2023: Registrations Open”Carefully chosen as the venue, ACannabis is thrilled to align with this world class venue that has a strong emphasis on sustainability and the environment.
Continue reading “ACannabis 2023 will be held at the newly built CENTREPIECE in Melbourne.”